Menu

References & Citations

Last Updated:  September 2022

  1. Engmann NJ, Golmakani MK, Miglioretti DL, Sprague BL, Kerlikowske K; Breast Cancer Surveillance Consortium. Population-attributable risk proportion of clinical risk factors for breast cancer. JAMA Oncol 2017; 3:1228–1236 [PubMed: 28152151]
  2. Shermis RB, Wilson KD, Doyle MT, et al. Supplemental breast cancer screening with molecular breast imaging for women with dense breast tissue. AJR 2016; 207:450–457 [PubMed: 27186635]
  3. Kuhl CK, Strobel K, Bieling H, Leutner C, Schild HH, Schrading S. Supplemental breast MR imaging screening of women with average risk of breast cancer. Radiology 2017; 283:361–370 [PubMed: 28221097]
  4. Sung JS, Lebron L, Keating D, et al. Performance of dual-energy contrast-enhanced digital mammography for screening women at increased risk of breast cancer. Radiology 2019; 293:81–88 [PubMed: 31453765]
  5. Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, Miglioretti DL. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med. 155(8):481-92, 2011.
  6. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 380(9855):1778-86, 2012.
  7. Nelson HD, Pappas M, Cantor A, Griffin J, Daeges M, Humphrey L. Harms of breast cancer screening: systematic review to update the 2009 U.S. Preventive Services Task Force Recommendation. Ann Intern Med. 164(4):256-67, 2016
  8. https://newsnetwork.mayoclinic.org/discussion/infographic/
  9. Nelson HD, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L. Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 U.S. Preventive Services Task Force Recommendation. Ann Intern Med. 164(4):244-55, 2016.
  10. Ciatto S, Houssami N, Bernardi D, et al. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study. Lancet Oncol 2013; 14:583–589 [PubMed: 23623721]
  11. Conant EF, Zuckerman SP, McDonald ES, et al. Five consecutive years of screening with digital breast tomosynthesis: outcomes by screening year and round. Radiology 2020; 295:285–293 [PubMed: 32154771]
  12. Leung JW, Sickles EA. Multiple bilateral masses detected on screening mammography: assessment of need for recall imaging. AJR 2000; 175:23–29 [PubMed: 10882241]
  13. Berg WA, Vourtsis A. Screening breast ultrasound using hand-held or automated technique in women with dense breasts. J Breast Imaging 2019; 1:283–296
  14. Berg WA et.al; Ultrasound as the Primary Screening Test for Breast Cancer: Analysis From ACRIN 6666.J Natl Cancer Inst. 2015 Dec 28;108(4). pii: djv367. doi: 10.1093/jnci/djv367. Print 2016 Apr
  15.  Shermis et al, Supplemental Breast Cancer Screening with Molecular Breast Imaging for Women with Dense Breast Tissue AJR 2016; 207:1–8
  16. Sardanelli F, Podo F, Santoro F, et al. High Breast Cancer Risk Italian 1 (HIB-CRIT-1) Study. Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the High Breast Cancer Risk Italian 1 Study): final results. Invest Radiol 2011; 46:94–105 [PubMed: 21139507]
  17. https://breastscreening.cancer.gov/statistics/benchmarks/screening/2009/table3
  18. Melnikow et al, Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force , Annals of Internal Medicine
  19. Sardanelli F, Podo F, Santoro F, et al. High Breast Cancer Risk Italian 1 (HIB-CRIT-1) Study. Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the High Breast Cancer Risk Italian 1 Study): final results. Invest Radiol 2011; 46:94–105 [PubMed: 21139507]
  20. Sorin V, Yagil Y, Yosepovich A, et al. Contrast-enhanced spectral mammography in women with intermediate breast cancer risk and dense breasts. AJR 2018; 211:[web]W267–W274 [PubMed: 30240292]
  21. Wendie A. Berg, MD, PhD, Elizabeth A. Rafferty, MD, Sarah M. Friedewald, MD, Carrie B. Hruska, PhD, Habib Rahbar, MD. Screening Algorithms in Dense Breasts: AJR Expert Panel Narrative Review.  American Journal of Roentgenology. 2021;216: 275-294. 10.2214/AJR.20.24436
  22. Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 356(3):227-36, 2007
  23. https://www.mayoclinic.org/tests-procedures/mammogram/in-depth/dense-breast-tissue/art-20123968
  24. https://www.komen.org/breast-cancer/risk-factor/family-history-cancer/
  25. https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-survival-rates.html
  26. Sprague BL, Gangnon RE, Burt V, et al. Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst 2014; 106:dju255 [PubMed: 25217577]
  27. Oppong, B. A., Dash, C., O’Neill, S., Li, Y., Makambi, K., Pien, E., Makariou, E., Coleman, T., & Adams-Campbell, L. L. (2017). Breast density in multiethnic women presenting for screening mammography. The Breast Journal, 24(3), 334–338. https://doi.org/10.1111/tbj.12941
  28. Molecular Breast Imaging Screening in Dense Breasts: Interim Analysis from the Density MATTERS Trial SBI Breast Imaging Symposium 2022, ClinicalTrials.gov Identifier: NCT03220893